These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band. Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819 [TBL] [Abstract][Full Text] [Related]
3. Early positive biomarker in relation to myocardial necrosis and impaired fatty acid metabolism in patients presenting with acute chest pain at an emergency room. Nagahara D; Nakata T; Hashimoto A; Takahashi T; Kyuma M; Hase M; Tsuchihashi K; Shimamoto K Circ J; 2006 Apr; 70(4):419-25. PubMed ID: 16565558 [TBL] [Abstract][Full Text] [Related]
4. [Multi-maker strategy for diagnosis of acute coronary syndrome]. Seino Y; Takano T Nihon Naika Gakkai Zasshi; 2004 Feb; 93(2):241-8. PubMed ID: 15007930 [No Abstract] [Full Text] [Related]
5. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes. Saenger AK; Jaffe AS Med Clin North Am; 2007 Jul; 91(4):657-81; xi. PubMed ID: 17640541 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of acute coronary syndrome. Achar SA; Kundu S; Norcross WA Am Fam Physician; 2005 Jul; 72(1):119-26. PubMed ID: 16035692 [TBL] [Abstract][Full Text] [Related]
7. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome. Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941 [TBL] [Abstract][Full Text] [Related]
8. Markers of acute coronary syndrome in emergency room. Loria V; Dato I; De Maria GL; Biasucci LM Minerva Med; 2008 Oct; 99(5):497-517. PubMed ID: 18971915 [TBL] [Abstract][Full Text] [Related]
9. Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes. Amos A; Newby LK Curr Cardiol Rep; 2005 Jul; 7(4):263-9. PubMed ID: 15987623 [TBL] [Abstract][Full Text] [Related]
10. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation. Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112 [TBL] [Abstract][Full Text] [Related]
11. Newer cardiac biomarkers in myocardial necrosis. Sachdeva A; Paul B J Assoc Physicians India; 2014 Oct; 62(10):83-4. PubMed ID: 25906536 [No Abstract] [Full Text] [Related]
12. Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18. Morrow DA; Sabatine MS; Brennan ML; de Lemos JA; Murphy SA; Ruff CT; Rifai N; Cannon CP; Hazen SL Eur Heart J; 2008 May; 29(9):1096-102. PubMed ID: 18339606 [TBL] [Abstract][Full Text] [Related]
14. Potential clinical application of novel cardiac biomarkers for acute myocardial infarction. Nursalim A; Suryaatmadja M; Panggabean M Acta Med Indones; 2013 Jul; 45(3):240-50. PubMed ID: 24045397 [TBL] [Abstract][Full Text] [Related]
15. [Leading symptoms of chest pain in the emergency room. Using cardiac markers for risk stratification]. Walter S; Carlsson J; Cuneo A; Tebbe U Dtsch Med Wochenschr; 2001 Jul; 126(27):771-8. PubMed ID: 11486476 [TBL] [Abstract][Full Text] [Related]
16. Paradigm shift from myocardium-derived to plaque-derived biomarkers for very early diagnosis of acute myocardial infarction. Imamura T Circ J; 2011; 75(6):1322-3. PubMed ID: 21532186 [No Abstract] [Full Text] [Related]
17. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome. Gibson CM; Karmpaliotis D; Kosmidou I; Murphy SA; Kirtane AJ; Budiu D; Ray KK; Herrmann HC; Lakkis N; Kovach R; French W; Blankenship J; Lui HH; Palabrica T; Jennings LK; Cohen DJ; Morrow DA; Am J Cardiol; 2006 May; 97(10):1473-7. PubMed ID: 16679086 [TBL] [Abstract][Full Text] [Related]
18. Troponin assays for the diagnosis of myocardial infarction and acute coronary syndrome: where do we stand? Eisenman A Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):509-14. PubMed ID: 16918269 [TBL] [Abstract][Full Text] [Related]
19. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654 [TBL] [Abstract][Full Text] [Related]
20. Individualizing therapy in acute coronary syndromes: using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy. Mo VY; De Lemos JA Curr Cardiol Rep; 2004 Jul; 6(4):273-8. PubMed ID: 15182604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]